SE0401031D0 - A new glucocorticoid replacement therapy - Google Patents
A new glucocorticoid replacement therapyInfo
- Publication number
- SE0401031D0 SE0401031D0 SE0401031A SE0401031A SE0401031D0 SE 0401031 D0 SE0401031 D0 SE 0401031D0 SE 0401031 A SE0401031 A SE 0401031A SE 0401031 A SE0401031 A SE 0401031A SE 0401031 D0 SE0401031 D0 SE 0401031D0
- Authority
- SE
- Sweden
- Prior art keywords
- glucocorticoid
- glucocorticoids
- relates
- replacement therapy
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Priority Applications (42)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0401031A SE0401031D0 (sv) | 2004-04-22 | 2004-04-22 | A new glucocorticoid replacement therapy |
PCT/EP2005/004400 WO2005102271A2 (en) | 2004-04-22 | 2005-04-21 | Pharmaceutical compositions for glucocorticoid replacement therapy |
NZ585340A NZ585340A (en) | 2004-04-22 | 2005-04-21 | Coated tablet composition comprising a coat for immediate release glucocorticoid and a core for extended release glucocorticoid for glucocorticoid replacement therapy |
ES16169413T ES2857600T3 (es) | 2004-04-22 | 2005-04-21 | Composiciones farmacéuticas para terapia de reemplazo con glucocorticoides |
PT57350761T PT1744730T (pt) | 2004-04-22 | 2005-04-21 | Composições farmacêuticas para terapia de substituição de glucocorticoide |
MEP-2016-250A ME02584B (de) | 2004-04-22 | 2005-04-21 | Pharmazeutische zusammensetzungen für die glucocorticoid-ersatztherapie |
CN201210499801.8A CN103006592B (zh) | 2004-04-22 | 2005-04-21 | 用于糖皮质激素替代疗法的药物组合物 |
MXPA06012011A MXPA06012011A (es) | 2004-04-22 | 2005-04-21 | Composiciones farmaceuticas para la terapia de reemplazo de glucocorticoides. |
EP05735076.1A EP1744730B1 (de) | 2004-04-22 | 2005-04-21 | Pharmazeutische zusammensetzungen für die glucocorticoid-ersatztherapie |
HUE05735076A HUE030546T2 (en) | 2004-04-22 | 2005-04-21 | A pharmaceutical composition for glucocorticoid replacement therapy |
LTEP16169413.8T LT3072507T (lt) | 2004-04-22 | 2005-04-21 | Farmacinės kompozicijos, skirtos pakaitinei gliukokortikoidų terapijai |
BRPI0510044A BRPI0510044B8 (pt) | 2004-04-22 | 2005-04-21 | composição farmacêutica, e, uso de uma composição farmacêutica |
SI200532291T SI3072507T1 (sl) | 2004-04-22 | 2005-04-21 | Farmacevtski sestavek za nadomestno zdravljenje z glukokortikoidi |
PL16169413T PL3072507T3 (pl) | 2004-04-22 | 2005-04-21 | Kompozycje farmaceutyczne do glikokortykoidowej terapii zastępczej |
ES05735076.1T ES2600556T3 (es) | 2004-04-22 | 2005-04-21 | Sustitución de las composiciones farmacéuticas para la terapia con glucocorticoides |
RS20210233A RS61501B1 (sr) | 2004-04-22 | 2005-04-21 | Farmaceutske kompozicije za terapiju zamene glukokortikoida |
LTEP05735076.1T LT1744730T (lt) | 2004-04-22 | 2005-04-21 | Farmacinės kompozicijos, skirtos pakaitinei gliukokortikoidų terapijai |
EP16169413.8A EP3072507B1 (de) | 2004-04-22 | 2005-04-21 | Pharmazeutische zusammensetzungen für glucocorticoid-ersatztherapie |
US11/587,514 US8425937B2 (en) | 2004-04-22 | 2005-04-21 | Pharmaceutical compositions for glucocorticoid replacement therapy |
PT161694138T PT3072507T (pt) | 2004-04-22 | 2005-04-21 | Composições farmacêuticas para terapia de substituição de glucocorticóide |
RS20160749A RS55198B1 (sr) | 2004-04-22 | 2005-04-21 | Farmaceutske kompozicije za terapiju zamene glukokortikoida |
CA2564000A CA2564000C (en) | 2004-04-22 | 2005-04-21 | Pharmaceutical compositions for glucocorticoid replacement therapy |
DK16169413.8T DK3072507T3 (da) | 2004-04-22 | 2005-04-21 | Farmaceutiske sammensætninger til glukokortikoidsubstitutionsterapi |
JP2007508863A JP5149618B2 (ja) | 2004-04-22 | 2005-04-21 | グルココルチコイド代償療法用の医薬組成物 |
DK05735076.1T DK1744730T3 (en) | 2004-04-22 | 2005-04-21 | Pharmaceutical compositions for glucocorticoid replacement therapy |
MX2013004889A MX344197B (es) | 2004-04-22 | 2005-04-21 | Composiciones farmaceuticas para la terapia de reemplazo de glucocorticoides. |
SG2013005244A SG188081A1 (en) | 2004-04-22 | 2005-04-21 | Pharmaceutical compositions for glucocorticoid replacement therapy |
HUE16169413A HUE053248T2 (hu) | 2004-04-22 | 2005-04-21 | Gyógyszerészeti készítmények glükokortikoid helyettesítõ terápiára |
PL05735076T PL1744730T3 (pl) | 2004-04-22 | 2005-04-21 | Kompozycje farmaceutyczne do glikokortykoidowej terapii zastępczej |
AU2005235370A AU2005235370B2 (en) | 2004-04-22 | 2005-04-21 | Pharmaceutical compositions for glucocorticoid replacement therapy |
CN2005800118623A CN1942176B (zh) | 2004-04-22 | 2005-04-21 | 用于糖皮质激素替代疗法的药物组合物 |
IL178776A IL178776A (en) | 2004-04-22 | 2006-10-19 | Dosage form of tablet coated with glucocorticoid replacement therapy |
ZA200609680A ZA200609680B (en) | 2004-04-22 | 2006-11-21 | Pharmaceutical compositions for glucocorticoid replacement therapy |
JP2012173158A JP5681679B2 (ja) | 2004-04-22 | 2012-08-03 | グルココルチコイド代償療法用の医薬組成物 |
US13/722,013 US20130129823A1 (en) | 2004-04-22 | 2012-12-20 | Pharmaceutical compositions for glucocorticoid replacement therapy |
HK13106780.6A HK1179525A1 (zh) | 2004-04-22 | 2013-06-07 | 用於糖皮質激素替代療法的藥物組合物 |
IL227375A IL227375A (en) | 2004-04-22 | 2013-07-08 | Dosage form of tablet coated with glucocorticoid replacement therapy |
US14/255,332 US10583146B2 (en) | 2004-04-22 | 2014-04-17 | Pharmaceutical compositions for glucocorticoid replacement therapy |
HRP20161380TT HRP20161380T1 (hr) | 2004-04-22 | 2016-10-24 | Farmaceutski sastavi za zamjensku terapiju glukokortikoidima |
CY20161101091T CY1118275T1 (el) | 2004-04-22 | 2016-10-26 | Φαρμακευτικες συνθεσεις για θεραπεια υποκαταστασης γλυκοκορτικοειδων |
HRP20210348TT HRP20210348T1 (hr) | 2004-04-22 | 2021-03-01 | Farmaceutski sastavi za terapiju zamjene glukokortikoida |
CY20211100191T CY1124074T1 (el) | 2004-04-22 | 2021-03-05 | Φαρμακευτικες συνθεσεις για θεραπεια υποκαταστασης γλυκοκορτικοειδων |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56420504P | 2004-04-22 | 2004-04-22 | |
SE0401031A SE0401031D0 (sv) | 2004-04-22 | 2004-04-22 | A new glucocorticoid replacement therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0401031D0 true SE0401031D0 (sv) | 2004-04-22 |
Family
ID=35197481
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0401031A SE0401031D0 (sv) | 2004-04-22 | 2004-04-22 | A new glucocorticoid replacement therapy |
Country Status (26)
Country | Link |
---|---|
US (3) | US8425937B2 (de) |
EP (2) | EP1744730B1 (de) |
JP (2) | JP5149618B2 (de) |
CN (2) | CN1942176B (de) |
AU (1) | AU2005235370B2 (de) |
BR (1) | BRPI0510044B8 (de) |
CA (1) | CA2564000C (de) |
CY (2) | CY1118275T1 (de) |
DK (2) | DK1744730T3 (de) |
ES (2) | ES2857600T3 (de) |
HK (1) | HK1179525A1 (de) |
HR (2) | HRP20161380T1 (de) |
HU (2) | HUE053248T2 (de) |
IL (2) | IL178776A (de) |
LT (2) | LT3072507T (de) |
ME (1) | ME02584B (de) |
MX (2) | MXPA06012011A (de) |
NZ (1) | NZ585340A (de) |
PL (2) | PL3072507T3 (de) |
PT (2) | PT1744730T (de) |
RS (2) | RS55198B1 (de) |
SE (1) | SE0401031D0 (de) |
SG (1) | SG188081A1 (de) |
SI (1) | SI3072507T1 (de) |
WO (1) | WO2005102271A2 (de) |
ZA (1) | ZA200609680B (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0401031D0 (sv) * | 2004-04-22 | 2004-04-22 | Duocort Ab | A new glucocorticoid replacement therapy |
US9925139B2 (en) | 2004-04-22 | 2018-03-27 | Acucort Ab | Pharmaceutical compositions for acute glucocorticoid therapy |
CA2630261A1 (en) * | 2005-12-06 | 2007-06-14 | Monosol Rx, Llc | Topical film compositions for delivery of actives |
FR2926722B1 (fr) * | 2008-01-25 | 2010-09-03 | Substipharm Dev | Formulation pharmaceutique appropriee pour la preparation de comprimes orodispersibles de prednisolone |
DE502008002621D1 (de) * | 2008-07-21 | 2011-03-31 | Falk Pharma Gmbh | Pharmazeutische Formulierung zur Behandlung des oberen Verdauungstraktes |
AU2010234320A1 (en) * | 2009-04-07 | 2011-10-27 | Duocort Pharma Ab | Improved glucocorticoid therapy |
PE20131024A1 (es) * | 2010-05-20 | 2013-10-10 | Duocort Pharma Ab | Composiciones basadas en glucocorticoides |
GB201119985D0 (en) * | 2011-11-19 | 2012-01-04 | Diurnal Ltd | Treatment of adrenal insufficiency |
GB201202433D0 (en) * | 2012-02-13 | 2012-03-28 | Diurnal Ltd | Controlled drug release |
JP2014086673A (ja) | 2012-10-26 | 2014-05-12 | Mitsubishi Electric Corp | モノリシック集積回路 |
US10265281B2 (en) | 2012-11-02 | 2019-04-23 | Murray And Poole Enterprises Ltd | Treatment or prevention of cardiovascular events via the administration of a colchicine derivative |
MX2015014656A (es) | 2013-04-16 | 2016-03-01 | Murray And Poole Entpr Ltd | Formulaciones de liberacion prolongada de colchicina y metodos de uso de las mismas. |
GB201308933D0 (en) * | 2013-05-17 | 2013-07-03 | Diurnal Ltd | Paediatric composition |
MX348595B (es) * | 2013-08-02 | 2017-06-21 | Laboratorio Raam De Sahuayo S A De C V | Composicion farmaceutica con agentes antiinflamatorios y proceso de produccion. |
SI2886108T2 (sl) | 2013-12-23 | 2023-02-28 | Dr. Falk Pharma Gmbh | Optimizirana farmacevtska formulacija za zdravljenje vnetnih sprememb požiralnika |
SG11201707525TA (en) * | 2015-03-30 | 2017-10-30 | Corcept Therapeutics Inc | Use of glucocorticoid receptor antagonists in combination with glucocorticoids to treat adrenal insufficiency |
CN107115308B (zh) * | 2016-02-23 | 2021-02-23 | 天津金耀集团有限公司 | 一种氢化可的松双相缓释片剂组合物 |
RU2748437C2 (ru) * | 2019-10-28 | 2021-05-25 | Федеральное государственное бюджетное учреждение науки Институт цитологии Российской академии наук (ИНЦ РАН) | Производное гидрокортизона в качестве средства для лечения болезни Альцгеймера |
FR3116439B1 (fr) * | 2020-11-26 | 2023-08-04 | Laboratoire Dielen | Comprimé pelliculé contenant au moins un principe actif, adapté à l’administration par voie orale dudit au moins un principe actif chez des sujets humains |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2260384C3 (de) * | 1972-12-09 | 1979-11-29 | Hoechst Ag, 6000 Frankfurt | Oral zu applizierendes Corticosteroid-Präparat |
US5316772A (en) * | 1990-12-19 | 1994-05-31 | Solvay & Cie, S.A. (Societe Anonyme) | Bilayered oral pharmaceutical composition with pH dependent release |
US5580578A (en) * | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
US5314697A (en) | 1992-10-23 | 1994-05-24 | Schering Corporation | Stable extended release oral dosage composition comprising loratadine and pseudoephedrine |
EP0745382B1 (de) * | 1994-01-31 | 2003-11-12 | Yamanouchi Pharmaceutical Co. Ltd. | Intraoral löslicher formpressling und verfahren zu seiner herstellung |
US5534263A (en) | 1995-02-24 | 1996-07-09 | Alza Corporation | Active agent dosage form comprising a matrix and at least two insoluble bands |
US5976573A (en) | 1996-07-03 | 1999-11-02 | Rorer Pharmaceutical Products Inc. | Aqueous-based pharmaceutical composition |
DE19718012C1 (de) | 1997-04-29 | 1998-10-08 | Jenapharm Gmbh | Verfahren zur Herstellung peroral anwendbarer fester Arzneiformen mit gesteuerter Wirkstoffabgabe |
US6602521B1 (en) * | 1998-09-29 | 2003-08-05 | Impax Pharmaceuticals, Inc. | Multiplex drug delivery system suitable for oral administration |
US6500459B1 (en) * | 1999-07-21 | 2002-12-31 | Harinderpal Chhabra | Controlled onset and sustained release dosage forms and the preparation thereof |
US6156743A (en) * | 1999-10-18 | 2000-12-05 | Whitcomb; John E. | Method of decreasing fatigue |
AR026148A1 (es) * | 2000-01-21 | 2003-01-29 | Osmotica Argentina S A | Dispositivo osmotico con pasaje preformado que aumenta de tamano |
HUP0501071A3 (en) | 2001-03-13 | 2007-06-28 | Penwest Pharmaceutical Co | Chronotherapeutic dosage forms |
IL157921A0 (en) * | 2001-03-15 | 2004-03-28 | Enteron Pharmaceuticals Inc | Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids |
GB0119848D0 (en) | 2001-08-15 | 2001-10-10 | Univ Sheffield | Delayed and sustained drug release |
US6682759B2 (en) * | 2002-02-01 | 2004-01-27 | Depomed, Inc. | Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs |
PL372290A1 (en) * | 2002-02-07 | 2005-07-11 | Pharmacia Corporation | Pharmaceutical dosage form for mucosal delivery |
GB0400031D0 (en) | 2004-01-03 | 2004-02-04 | Univ Sheffield | Depression treatment |
US9925139B2 (en) | 2004-04-22 | 2018-03-27 | Acucort Ab | Pharmaceutical compositions for acute glucocorticoid therapy |
SE0401031D0 (sv) * | 2004-04-22 | 2004-04-22 | Duocort Ab | A new glucocorticoid replacement therapy |
GB0623740D0 (en) | 2006-11-28 | 2007-01-10 | Diurnal Ltd | Treatment of disease |
AU2010234320A1 (en) * | 2009-04-07 | 2011-10-27 | Duocort Pharma Ab | Improved glucocorticoid therapy |
PE20131024A1 (es) | 2010-05-20 | 2013-10-10 | Duocort Pharma Ab | Composiciones basadas en glucocorticoides |
-
2004
- 2004-04-22 SE SE0401031A patent/SE0401031D0/xx unknown
-
2005
- 2005-04-21 WO PCT/EP2005/004400 patent/WO2005102271A2/en active Application Filing
- 2005-04-21 SI SI200532291T patent/SI3072507T1/sl unknown
- 2005-04-21 ES ES16169413T patent/ES2857600T3/es active Active
- 2005-04-21 HU HUE16169413A patent/HUE053248T2/hu unknown
- 2005-04-21 CA CA2564000A patent/CA2564000C/en active Active
- 2005-04-21 ES ES05735076.1T patent/ES2600556T3/es active Active
- 2005-04-21 SG SG2013005244A patent/SG188081A1/en unknown
- 2005-04-21 NZ NZ585340A patent/NZ585340A/en active IP Right Revival
- 2005-04-21 CN CN2005800118623A patent/CN1942176B/zh active Active
- 2005-04-21 LT LTEP16169413.8T patent/LT3072507T/lt unknown
- 2005-04-21 HU HUE05735076A patent/HUE030546T2/en unknown
- 2005-04-21 PT PT57350761T patent/PT1744730T/pt unknown
- 2005-04-21 PT PT161694138T patent/PT3072507T/pt unknown
- 2005-04-21 MX MXPA06012011A patent/MXPA06012011A/es active IP Right Grant
- 2005-04-21 BR BRPI0510044A patent/BRPI0510044B8/pt active IP Right Grant
- 2005-04-21 MX MX2013004889A patent/MX344197B/es unknown
- 2005-04-21 JP JP2007508863A patent/JP5149618B2/ja active Active
- 2005-04-21 DK DK05735076.1T patent/DK1744730T3/en active
- 2005-04-21 ME MEP-2016-250A patent/ME02584B/de unknown
- 2005-04-21 DK DK16169413.8T patent/DK3072507T3/da active
- 2005-04-21 RS RS20160749A patent/RS55198B1/sr unknown
- 2005-04-21 EP EP05735076.1A patent/EP1744730B1/de active Active
- 2005-04-21 LT LTEP05735076.1T patent/LT1744730T/lt unknown
- 2005-04-21 US US11/587,514 patent/US8425937B2/en active Active
- 2005-04-21 CN CN201210499801.8A patent/CN103006592B/zh active Active
- 2005-04-21 EP EP16169413.8A patent/EP3072507B1/de active Active
- 2005-04-21 PL PL16169413T patent/PL3072507T3/pl unknown
- 2005-04-21 RS RS20210233A patent/RS61501B1/sr unknown
- 2005-04-21 AU AU2005235370A patent/AU2005235370B2/en active Active
- 2005-04-21 PL PL05735076T patent/PL1744730T3/pl unknown
-
2006
- 2006-10-19 IL IL178776A patent/IL178776A/en active IP Right Grant
- 2006-11-21 ZA ZA200609680A patent/ZA200609680B/xx unknown
-
2012
- 2012-08-03 JP JP2012173158A patent/JP5681679B2/ja active Active
- 2012-12-20 US US13/722,013 patent/US20130129823A1/en not_active Abandoned
-
2013
- 2013-06-07 HK HK13106780.6A patent/HK1179525A1/zh unknown
- 2013-07-08 IL IL227375A patent/IL227375A/en active IP Right Grant
-
2014
- 2014-04-17 US US14/255,332 patent/US10583146B2/en active Active
-
2016
- 2016-10-24 HR HRP20161380TT patent/HRP20161380T1/hr unknown
- 2016-10-26 CY CY20161101091T patent/CY1118275T1/el unknown
-
2021
- 2021-03-01 HR HRP20210348TT patent/HRP20210348T1/hr unknown
- 2021-03-05 CY CY20211100191T patent/CY1124074T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1124074T1 (el) | Φαρμακευτικες συνθεσεις για θεραπεια υποκαταστασης γλυκοκορτικοειδων | |
ATE450251T1 (de) | Liposomale formulierungen mit dihydrosphingomyelin und verfahren zu ihrer verwendung | |
WO2005112981A3 (en) | Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells | |
PH12017502286A1 (en) | Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi) | |
ATE529125T1 (de) | Pharmazeutische zusammensetzungen und verfahren zur beschleunigung der wundheilung | |
EA200700251A1 (ru) | Амидосоединения и их применение в качестве фармацевтических средств | |
EA200900203A1 (ru) | Избирательные модуляторы рецептора андрогенов, их аналоги, производные и применение | |
EA200602062A1 (ru) | Амидосоединения и их применение в качестве фармацевтических средств | |
ATE544460T1 (de) | Zusammensetzungen und verfahren für eine gesunde schwangerschaft | |
EA200600254A1 (ru) | Человеческие нейтрализующие антитела к фактору роста нервов (ngf) в качестве селективных ингибиторов метаболического пути ngf | |
ATE544748T1 (de) | Zusammensetzungen und verfahren für die behandlung von zellproliferationserkrankungen | |
IL178775A (en) | Pharmaceuticals containing glucocorticoid for use in the treatment of disorders requiring acute glucocorticoid therapy | |
NO20072322L (no) | Laktamforbindelser og anvendelse derav som farmasoytiske midler | |
WO2006014678A3 (en) | Compositions and methods of using angiopoietin-like 4 protein | |
EA200600414A1 (ru) | ПРОИЗВОДНЫЕ БОРОНОВОЙ КИСЛОТЫ (ВАРИАНТЫ), ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ, КОМПОЗИЦИЯ ДЛЯ ИНГИБИРОВАНИЯ АКТИВНОСТИ NF-kB И ДЕГРАДАЦИИ БЕЛКА И СПОСОБЫ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ (ВАРИАНТЫ) | |
Wang et al. | Mineral trioxide aggregate enhances the osteogenic capacity of periodontal ligament stem cells via NF‐κB and MAPK signaling pathways | |
ATE515268T1 (de) | Verwendung von op-1 zur behandlung von knorpeldefekten | |
HK1109062A1 (en) | Compositions and methods of use for treatment of mammalian diseases | |
DE602004031134D1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
de Campos et al. | Smoking modulates gene expression of type I collagen, bone sialoprotein, and osteocalcin in human alveolar bone | |
DE602006009786D1 (de) | Anwendung von molekülen und verfahren zur behandlung von mit mcp-1/ccr2 assoziierten krankheiten | |
EA200701599A1 (ru) | Способ и композиция для восстановления сердечной ткани | |
ATE469659T1 (de) | Stibogluconate-natrium und il-2 zur krebsbehandlung | |
ATE556134T1 (de) | Mesenchymstammzellen und verwendungendafür | |
WO2006102979A3 (de) | Entzündungsmarker und kombinationen davon als biochemische marker bei kardiovaskulären erkrankungen |